ARDX
Price
$5.01
Change
-$0.15 (-2.91%)
Updated
Jan 17 closing price
Capitalization
1.19B
46 days until earnings call
PCVX
Price
$85.30
Change
-$2.53 (-2.88%)
Updated
Jan 17 closing price
Capitalization
10.63B
44 days until earnings call
Ad is loading...

ARDX vs PCVX

Header iconARDX vs PCVX Comparison
Open Charts ARDX vs PCVXBanner chart's image
Ardelyx
Price$5.01
Change-$0.15 (-2.91%)
Volume$5.83M
Capitalization1.19B
Vaxcyte
Price$85.30
Change-$2.53 (-2.88%)
Volume$1.61M
Capitalization10.63B
ARDX vs PCVX Comparison Chart
Loading...
ARDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARDX vs. PCVX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARDX is a Hold and PCVX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (ARDX: $5.01 vs. PCVX: $85.30)
Brand notoriety: ARDX and PCVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARDX: 124% vs. PCVX: 117%
Market capitalization -- ARDX: $1.19B vs. PCVX: $10.63B
ARDX [@Biotechnology] is valued at $1.19B. PCVX’s [@Biotechnology] market capitalization is $10.63B. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARDX’s FA Score shows that 0 FA rating(s) are green whilePCVX’s FA Score has 0 green FA rating(s).

  • ARDX’s FA Score: 0 green, 5 red.
  • PCVX’s FA Score: 0 green, 5 red.
According to our system of comparison, PCVX is a better buy in the long-term than ARDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARDX’s TA Score shows that 4 TA indicator(s) are bullish while PCVX’s TA Score has 5 bullish TA indicator(s).

  • ARDX’s TA Score: 4 bullish, 1 bearish.
  • PCVX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ARDX is a better buy in the short-term than PCVX.

Price Growth

ARDX (@Biotechnology) experienced а -1.18% price change this week, while PCVX (@Biotechnology) price change was +5.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

ARDX is expected to report earnings on May 01, 2025.

PCVX is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PCVX($10.6B) has a higher market cap than ARDX($1.19B). PCVX YTD gains are higher at: 4.202 vs. ARDX (-1.183). ARDX has higher annual earnings (EBITDA): -53.06M vs. PCVX (-528.22M). PCVX has more cash in the bank: 2.18B vs. ARDX (190M). PCVX has less debt than ARDX: PCVX (28M) vs ARDX (104M). ARDX has higher revenues than PCVX: ARDX (252M) vs PCVX (0).
ARDXPCVXARDX / PCVX
Capitalization1.19B10.6B11%
EBITDA-53.06M-528.22M10%
Gain YTD-1.1834.202-28%
P/E RatioN/AN/A-
Revenue252M0-
Total Cash190M2.18B9%
Total Debt104M28M371%
FUNDAMENTALS RATINGS
ARDX: Fundamental Ratings
ARDX
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
51
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARDXPCVX
RSI
ODDS (%)
N/A
Bullish Trend 11 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 11 days ago
87%
Bullish Trend 11 days ago
82%
Momentum
ODDS (%)
Bullish Trend 11 days ago
86%
Bearish Trend 11 days ago
82%
MACD
ODDS (%)
Bullish Trend 11 days ago
90%
Bullish Trend 11 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
84%
Bearish Trend 11 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
83%
Bearish Trend 11 days ago
81%
Advances
ODDS (%)
Bullish Trend 12 days ago
86%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 23 days ago
81%
BollingerBands
ODDS (%)
N/A
Bullish Trend 11 days ago
84%
Aroon
ODDS (%)
N/A
Bearish Trend 11 days ago
82%
View a ticker or compare two or three
Ad is loading...
ARDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VRIG25.180.01
+0.06%
Invesco Variable Rate Investment Grd ETF
DGIN42.530.02
+0.06%
VanEck Digital India ETF
FDEV27.57N/A
N/A
Fidelity International Multifactor ETF
BIV74.70-0.03
-0.04%
Vanguard Interm-Term Bond ETF
JUCY22.84-0.02
-0.09%
Aptus Enhanced Yield ETF

ARDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARDX has been loosely correlated with VCYT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ARDX jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARDX
1D Price
Change %
ARDX100%
-2.91%
VCYT - ARDX
45%
Loosely correlated
-1.27%
HRTX - ARDX
41%
Loosely correlated
+3.82%
PTGX - ARDX
39%
Loosely correlated
+0.77%
XENE - ARDX
39%
Loosely correlated
-2.78%
PCVX - ARDX
35%
Loosely correlated
-2.88%
More

PCVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with ORKA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then ORKA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCVX
1D Price
Change %
PCVX100%
-2.88%
ORKA - PCVX
59%
Loosely correlated
-2.78%
LOGC - PCVX
45%
Loosely correlated
+1.93%
RXRX - PCVX
42%
Loosely correlated
+2.03%
DYN - PCVX
41%
Loosely correlated
-4.33%
DNLI - PCVX
38%
Loosely correlated
+1.20%
More